Department
Women's Health
Pelvic radiation injury (FDA), endometriosis (investigational)
HBOT Applications
Pelvic Radiation Injury
HBOT for late radiation tissue injury in pelvic structures (radiation cystitis, proctitis, vaginal stenosis) following gynaecological cancer radiotherapy. Cross-references the FDA-approved Delayed Radiation Injury indication; the women's-health context emphasises pelvic-specific manifestations.
Protocol
Pressure
2.0 – 2.4 ATA
Duration
90 min
Sessions
30 – 60
Frequency
Once daily, 5×/week
Evidence basis: UHMS / Standard of Care
Endometriosis
Investigational application supported by translational evidence in rodent models and one registered randomised trial (HEROES, NCT06579040) currently recruiting. No published human clinical evidence yet; HBOT is positioned as an investigational adjunct, not standard of care.
Protocol
Pressure
Not standardised
Duration
Not standardised
Sessions
Not standardised (HEROES trial protocol pending publication)
Frequency
Not standardised
Evidence basis: Translational + Registered Trial Awaiting Results